ABSTRACT
Peptoanaerobacter stomatis is a newly appreciated taxon associated with periodontal diseases; however, little is known about the organism's pathogenic potential or its interaction with the host immune response. Neutrophils are the most abundant innate immune cell present in the gingival tissue and function to constrain the oral microbial challenge. However, some periodontal pathogens have developed strategies to evade phagocytosis and killing by neutrophils. Therefore, to begin to understand the role of P. stomatis in periodontitis, we studied its interactions with human neutrophils. Our data showed that after 30 min of incubation, neutrophils failed to engulf P. stomatis efficiently; however, when P. stomatis was internalized, it was promptly eradicated. P. stomatis challenge induced a robust intracellular respiratory burst; however, this response did not contribute to bacterial killing. Minimal superoxide release was observed by direct bacterial challenge; however, P. stomatis significantly increased N-formyl-methionyl-leucyl phenylalanine (fMLF)-stimulated superoxide release to an extent similar to that of cells primed with tumor necrosis factor alpha (TNF-α). When neutrophils were challenged with P. stomatis, 52% of the bacterium-containing phagosomes were enriched for the specific granule marker lactoferrin and 82% with the azurophil granule marker elastase. P. stomatis challenge stimulated exocytosis of the four neutrophil granule subtypes. Moreover, P. stomatis susceptibility to extracellular killing could be attributed to the exocytosis of antimicrobial components present in neutrophil granules. Priming neutrophils for an enhanced respiratory burst together with promoting granule content release could contribute to the chronic inflammation and tissue destruction that characterize periodontal diseases.
KEYWORDS: Peptoanaerobacter stomatis, periodontitis, killing mechanisms, neutrophil, periodontal immunology
INTRODUCTION
Periodontal diseases are one of the most prevalent infectious diseases worldwide, affecting almost one-half of the U.S. population (1). These disorders lead to destruction of the hard and soft tissues of the periodontium (2, 3) and are also associated with serious systemic conditions such as rheumatoid arthritis, cardiovascular disease, diabetes, and adverse pregnancy outcomes (4–6). Periodontitis is a polymicrobial chronic inflammatory disease, and the understanding of the disease etiology developed through the extensive study of a limited number of species, including Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola (7, 8). More recently, culture-independent techniques have identified a variety of other bacterial species that increase in number in disease (9). Peptoanaerobacter stomatis is one such newly appreciated potential oral pathogen that is present in oral biofilms in patients with periodontal diseases in higher numbers than in healthy individuals (10–12). Sizova et al. (12) classified this organism as a novel genus and species within the family of Peptostreptococcaceae, and P. stomatis represents the first known cultivable member of the human oral taxon 081 (13). P. stomatis is a Gram-positive obligate anaerobic rod with round ends, with a diameter of 0.5 to 0.7 μm and a length of 1.0 to 2.3 μm, often forming chains (12), and highly motile due to peritrichous flagella (14). In addition to periodontitis, P. stomatis is associated with dentoalveolar abscesses and endodontic infections (14).
As a major component of the innate host response, neutrophils contribute to the maintenance of a healthy gingival crevice (15, 16). Following phagocytosis, bacteria are killed by oxygen-dependent and -independent mechanisms, which can also act on extracellular microorganisms (17, 18). While the generation of high concentrations of reactive oxygen species (ROS), such as superoxide ion (O2−), is a key antimicrobial feature (19), if this response is not regulated properly, it can lead to severe tissue destruction of the periodontium, characteristic of periodontal disease (2). Another neutrophil killing mechanism, which does not involve oxygen consumption, involves mobilization of neutrophil granule subtypes (18). Upon activation, these granules fuse with the phagosome or the plasma membrane, releasing their antimicrobial components either inside the bacterium-containing phagosome or to the extracellular environment (21). The components of the secretory vesicles and the gelatinase granules also aid in early neutrophil mechanisms such as adhesion, migration, chemotaxis, and extravasation; therefore, they are the first to undergo exocytosis (22, 23). The last granules to be mobilized are the specific and azurophil granules, which contribute to phagosome maturation and contain the most microbicidal and cytotoxic components (24, 25).
In this study, we demonstrate that neutrophils have a low phagocytic ability toward P. stomatis, with 22% of the bacteria internalized after 30 min of challenge. However, once P. stomatis is internalized, it is eradicated efficiently in an ROS-independent manner. More than 65% of P. stomatis remains attached to the neutrophil plasma membrane, which might contribute to priming of N-formyl-methionyl-leucyl phenylalanine (fMLF)-stimulated superoxide release. In addition, P. stomatis induced robust exocytosis of the four neutrophil granule subtypes.
RESULTS
Neutrophils have a low phagocytic efficiency for P. stomatis.
High numbers of neutrophils are recruited to the gingival tissue and the gingival crevice, where they phagocytose and destroy periodontal bacteria (2, 16). Successful periodontal pathogens, however, can resist neutrophil killing mechanisms. For example, the keystone pathogen, P. gingivalis, prevents neutrophil phagocytosis by a complex signaling mechanism that involves activation and cross talk between C5aR and Toll-like receptor 2 (TLR2), leading to suppression of actin polymerization (36). To assess the susceptibility or recalcitrance of P. stomatis to neutrophil phagocytosis, engulfment of carboxyfluorescein succinimidyl ester (CFSE)-labeled P. stomatis was measured by imaging flow cytometry (Fig. 1A). Under the control condition, 45 to 50% of neutrophils internalized Staphylococcus aureus after a 30-min challenge, consistent with previous reports (30) (Fig. 1B). However, only 22% of the neutrophils internalized P. stomatis after 30 min, with a modest, nonsignificant increase after 120 min of challenge (Fig. 1B). Since serum opsonization increases neutrophils' phagocytic ability, cells were challenged with serum-opsonized P. stomatis. A similar level of CFSE-positive neutrophils, less than 25%, was observed with both opsonized as well as nonopsonized P. stomatis (Fig. 1C). Hence, all further experiments were conducted with nonopsonized bacteria.
To confirm the low phagocytic ability of neutrophils toward P. stomatis and to distinguish between surface-associated bacteria and fully engulfed bacteria, the neutrophil plasma membrane was stained with wheat germ agglutinin (WGA) prior to bacterial challenge. Confocal microscopy showed that, similar to the data obtained by imaging flow cytometry, at a multiplicity of infection (MOI) of 10, only 11% of neutrophils had fully engulfed the bacteria and 25% of the cells had both surface-bound and engulfed bacteria, with the majority of the neutrophils showing surface-bound bacteria only (Fig. 1D and E).
Bacterial viability upon neutrophil challenge.
The data in Fig. 1 show that P. stomatis is more resistant to neutrophil phagocytosis than is S. aureus. Therefore, the next step was to determine the extent to which internalized organisms are killed by neutrophils. Plate counting for P. stomatis results in a very low percent recovery, so to overcome this limitation, Baclight staining was used to determine bacterial viability (21). Neutrophils were challenged with P. stomatis, and bacterial viability was determined using DAPI (4′,6-diamidino-2-phenylindole) for intact bacteria and Sytox Green for bacteria with compromised membranes (Fig. 2A). After 30 min of P. stomatis challenge, 87% of the extracellular bacteria were viable, 70% of the plasma membrane-bound bacteria were viable, and 42% of the internalized bacteria were viable (Fig. 2B). In contrast, after 120 min of neutrophil challenge, bacterial survival decreased significantly compared to the 30-min challenge, with 28% of bacteria remaining viable either extracellularly or as membrane-bound or internalized bacteria (Fig. 2C). The percent viabilities of the bacterial inocula used for the assays were 90% for 30 min and 87% for 120 min (Fig. 2D). After a longer incubation time with neutrophils, the survival rates of both extracellular and internalized bacteria are significantly reduced. However, 25 to 28% of the bacteria after 2 h of exposure to the neutrophils are able to resist killing by neutrophils.
P. stomatis induces a robust neutrophil respiratory burst response, which did not contribute to bacterial killing.
Upon recognition and binding of bacteria, neutrophils initiate the phagocytic process, which is accompanied by assembly and activation of the NADPH oxidase complex, with reduction of oxygen and generation of high levels of reactive oxygen species within the phagosome (19, 29). Bacterial pathogens can manipulate the respiratory burst response as a way to withstand neutrophil killing mechanisms. A nitroblue tetrazolium (NBT) assay was utilized to localize ROS accumulation inside P. stomatis phagosomes (29). Minimal blue deposits were observed in unstimulated neutrophils, whereas defined blue deposits accumulated in both S. aureus and P. stomatis phagosomes (Fig. 3A). To quantify intracellular ROS generation, neutrophils were challenged with either S. aureus or P. stomatis, and intracellular ROS production was analyzed by flow cytometry. As shown in Fig. 3B, P. stomatis induced a time-dependent increase in intracellular ROS production that was significantly higher than the response to S. aureus after 30 min of bacterial challenge.
Depending on the stimuli, neutrophils can also assemble the NADPH oxidase at the plasma membrane, and consequently, the ROS generated is released outside the cell (29). Next, we examined if P. stomatis challenge would also induce extracellular ROS. Unlike intracellular ROS, the P. stomatis-challenged neutrophils showed minimal superoxide release, which was similar to basal levels from unstimulated cells (Fig. 3C).
The degree of neutrophil activation is tightly regulated due to the deleterious consequences that a fully activated cell can have on host tissue. Neutrophils can display a minimal degree of activation upon exposure to an agonist but will exhibit an enhanced response upon exposure to a second stimulus, a phenotype known as priming. Circulating neutrophils as well as cells isolated from the oral cavity from chronic periodontitis patients have a primed phenotype (27, 32). Our data indicate that more than 65% of P. stomatis cells remain associated with the neutrophil surface without inducing extracellular release of ROS. To examine the ability of P. stomatis to prime neutrophils, cells were first exposed to P. stomatis for 10 min, followed by a second stimulus of fMLF. Similar to the control tumor necrosis factor alpha (TNF-α)-induced priming of the respiratory burst response, preexposure of neutrophils to P. stomatis significantly enhanced the fMLF-stimulated superoxide release (Fig. 3D). P. stomatis on its own did not trigger superoxide release, a phenotype shared by all priming agents (33, 34). Collectively, these results indicate that P. stomatis induces a robust intracellular ROS production with minimal activation of the NADPH oxidase at the neutrophil plasma membrane. However, P. stomatis can prime the neutrophils for fMLF-stimulated superoxide release.
To address whether the robust intracellular ROS induced upon P. stomatis challenge contributes to bacteria killing, an inhibitor of the NADPH oxidase activity, diphenyleneiodonium (DPI), was used. After 30 min of exposure to human neutrophils, this set of donors showed that 31% of the internalized P. stomatis organisms and between 81% of the extracellular bacteria remained viable as determined by BacLight (Fig. 4A and B). Blocking the NADPH oxidase with DPI did not increase P. stomatis intracellular or extracellular survival after 30 min of bacterial challenge (Fig. 4A and B). In addition, DPI treatment did not affect P. stomatis survival (data not shown). However, DPI significantly reduced P. stomatis-induced intracellular ROS production (Fig. 4C), suggesting that at the 30-min time point, the respiratory burst response is not the major antimicrobial weapon used by neutrophils to effectively kill P. stomatis. However, we observed a significant decrease of P. stomatis extracellular survival after 120 min (Fig. 2C). P. stomatis induced minimal extracellular superoxide release after 120 min of neutrophil challenge (data not shown). To determine if the minimal amount of superoxide released after 120 min of neutrophil challenge could contribute to the significant extracellular bacterial killing, neutrophils from a patient with autosomal chronic granulomatous disease (CGD), with impaired oxidase function, were challenged with P. stomatis for 30 and 120 min, and bacterial survival was determined by BacLight. CGD patient neutrophils showed a similar ability to kill extracellular and intracellular P. stomatis isolates, as observed with neutrophils from healthy donors. After 30 min of P. stomatis challenge of CGD neutrophils, 70% of extracellular bacteria were viable, and by 120 min only 21% of extracellular bacteria survived (Fig. 4D). Collectively, these results strongly indicate that the ability of neutrophils to kill extracellular as well as intracellular P. stomatis is ROS independent.
P. stomatis phagosomes are enriched with both specific and azurophil granules.
Specific and azurophil granule fusion to bacterium-containing phagosomes is crucial for optimal respiratory burst responses and for phagosome maturation and efficient bacterial killing (19). The recruitment of specific and azurophil granules to S. aureus or P. stomatis phagosomes was examined by immunostaining against each granule subtype content protein, lactoferrin and elastase, respectively, and analyzed by confocal microscopy. Under the control condition, more than 60% of S. aureus phagosomes were enriched for the specific granule protein, lactoferrin, after 30 min of neutrophil challenge (Fig. 5A and B). In neutrophils challenged with P. stomatis, 53% of the phagosomes were enriched for lactoferrin (Fig. 5A and B). P. stomatis phagosomes were highly enriched for the azurophil granule protein, elastase, after 30 min of neutrophil challenge, similar to what was seen in the control with S. aureus (Fig. 5C and D). These results show that neutrophil-specific and azurophil granules fuse with P. stomatis-containing phagosomes.
P. stomatis induces robust neutrophil granule exocytosis.
Our data thus far showed that P. stomatis is resistant to internalization by human neutrophils and that the low numbers of this bacterium that are engulfed are killed independently of ROS, resulting mainly from phagosome maturation. However, P. stomatis induced robust intracellular ROS production and was able to prime neutrophils for a significant release of superoxide radicals upon subsequent stimulation with a formylated bacterial peptide. Hence, we wanted to determine if P. stomatis would induce neutrophil activation through promoting granule exocytosis. Stimulation of human neutrophils with P. stomatis resulted in a robust secretory vesicle exocytosis, which was significantly higher than the response induced by fMLF (Fig. 6A). To determine if P. stomatis-induced granule mobilization was comparable to the response induced by other oral bacteria, neutrophils were challenged with P. gingivalis. Our data show that P. stomatis mobilization of secretory vesicles was similar to the response induced by P. gingivalis (Fig. 6B). In addition, significantly higher levels of MMP-9, a protein found within gelatinase granules, were induced upon P. stomatis challenge than with fMLF (Fig. 6C). To determine if P. stomatis induction of gelatinase granule exocytosis resulted in the extracellular release of active matrix metalloproteinases, supernatants collected from P. stomatis-challenged neutrophils were analyzed by gelatin zymography. Figure 6D and E show prominent bands at 92 kDa, the corresponding molecular mass of MMP-9, for the positive control and for fMLF- and P. stomatis-stimulated neutrophils. In addition, a higher-molecular-mass band, around 130 kDa, was also observed under the P. stomatis supernatant conditions, which might correspond to an MMP-9 dimer with neutrophil gelatinase-associated lipocalin (NGAL) as previously reported (35). In contrast, the supernatants collected from P. gingivalis-challenged human neutrophils showed a significantly lower band intensity at 92 kDa when analyzed by gelatin zymography (Fig. 6F). No bands were observed when the supernatant from P. stomatis culture was examined by zymography (Fig. 6D), indicating that gelatinase activity originates from the neutrophils.
The release of neutrophil granules is hierarchical, requiring stronger stimuli to induce mobilization of specific and azurophil granules than for secretory vesicles and gelatinase granules (23). Hence, exocytosis of specific and azurophil granules upon P. stomatis challenge was measured by the increase of plasma membrane expression of CD66b and CD63, respectively. A significant increase of CD66b expression was triggered by P. stomatis challenge compared to fMLF (Fig. 7A). The two oral pathogens P. stomatis and P. gingivalis triggered a similar increase of CD66b plasma membrane expression, which was significantly higher than basal levels (Fig. 7B). Figure 7C shows that P. stomatis challenge also resulted in a significant increase of CD63 plasma membrane expression, which was dependent on bacterial dose. Thus far, our data showed that P. stomatis and P. gingivalis demonstrate similar ability to induce secretory vesicles and specific granule exocytosis, but P. stomatis was able to induce the release of higher levels of active gelatinase/MMP-9 than P. gingivalis. However, P. gingivalis induced a significantly higher increase of CD63 plasma membrane expression than P. stomatis at MOIs of 50 and 100 (Fig. 7D). To further confirm the exocytic ability of P. stomatis toward azurophil granule mobilization, the levels of myeloperoxidase (MPO), a major enzyme present in the matrix of azurophil granules, were determined. Similar to the flow-cytometric results, levels of MPO increased in a bacterial-dose-dependent manner (Fig. 7E). In addition, longer exposure between neutrophils and P. stomatis, at an MOI of 10, triggered a time-dependent increase of MPO levels (Fig. 7F). Collectively, these results demonstrate that P. stomatis interaction with human neutrophils triggered a robust exocytosis of the four different neutrophil granule subtypes.
DISCUSSION
High-throughput sequencing analyses have revealed that the composition of the oral microbiome from healthy and diseased periodontal sites is very diverse and that shifts from a symbiotic to a dysbiotic community occur as the disease progresses (7–10). Species such as P. stomatis that are detected with higher frequency in periodontal disease sites than in healthy sites are emerging as periodontal pathogens (10, 12, 14).
Neutrophils are the main innate immune cell present in the oral cavity, and interactions with the oral microbial community are critical in both oral health and disease (16, 32). Periodontal pathogens have the capacity to evade or manipulate neutrophil functional responses to promote inflammation (36). The goal of the present study was to begin to characterize the potential pathogenic profile of P. stomatis in the context of interactions with human neutrophils. We found that P. stomatis is resistant to neutrophil phagocytosis both when unopsonized and when opsonized with human serum. Oxygen-independent mechanisms were primarily responsible for killing engulfed as well as extracellular bacteria, and P. stomatis induced robust degranulation of the four neutrophil granule subtypes. The significant decrease in extracellular bacterial survival after 120 min of challenge most likely could be attributed to the stimulated exocytosis of antimicrobial components found in neutrophil granules. Our results strongly indicate that proteins and/or peptides present inside neutrophil granules have antimicrobial properties toward P. stomatis, and studies to examine this are under current investigation in our laboratory.
In periodontal disease, activated neutrophils traffic from the blood into the gingival tissue to control microbial challenge, and during that journey oxygen radicals as well as antimicrobial peptides that can contribute to tissue damage are released (2, 16, 37). Periodontal pathogens have been shown to enhance the release of oxygen radicals. For example, dentilisin, a protease released from T. denticola, is involved in generation of ROS by human neutrophils through activation of complement (38). Neutrophil interaction with another oral pathogen, Fusobacterium nucleatum, results in high intracellular as well as extracellular ROS production (39). Both T. denticola and F. nucleatum, in the absence of opsonization, are efficiently internalized by neutrophils (40). P. stomatis, in the absence of serum opsonization, induced a robust intracellular ROS production, similar to that reported for other oral bacteria, albeit P. stomatis exhibits a low phagocytic uptake. The fusion of azurophil granules to P. stomatis-containing phagosomes would contribute to the high intracellular ROS detected by flow cytometry. Additionally, in another Gram-positive pathogen, Listeria monocytogenes, peptidoglycan induces high ROS production in neutrophils through activation of TLR2 (41). Therefore, it is possible that bacterial components, such as peptidoglycan and/or the peritrichous flagella, through activation of TLR2 and/or TLR5, could be responsible for the robust intracellular ROS generation. Studies to determine which neutrophil receptor(s) is involved in P. stomatis-induced neutrophil activation are under way in our laboratory.
Activation of the NADPH oxidase is initiated upon phagocytosis of microbial pathogens with the generation of superoxide radicals, which are quickly converted to hydrogen peroxide. In addition, the phagocytic vacuole is enriched by microbicidal peptides derived from the matrix of the different neutrophil granules upon fusion with the phagosome (18, 19). Hence, both oxygen-dependent and -independent mechanisms combine to ensure an efficient microbicidal environment inside the neutrophil phagosome (18). Several oral pathogens are protected against neutrophils' oxidative antimicrobial killing by the presence of enzymes such as superoxide dismutase, catalase, and rubrerythrin (42, 43). In the current study, neutrophils mounted a robust intracellular respiratory burst upon phagocytosis of P. stomatis; however, this antimicrobial response was not the main contributor to bacterial killing, since blocking the NADPH oxidase did not enhance P. stomatis survival. Moreover, the antimicrobial capacity toward P. stomatis from CGD neutrophils, which have impaired ability to generate ROS, was similar to the response observed by neutrophils with a functional NADPH oxidase. Phagosome maturation is accomplished in neutrophils by recruitment and fusion of specific and azurophil granules. Fusion of specific granules to bacterium-containing phagosomes results in the delivery of antimicrobial components, such as lactoferrin, to the phagosome. In our study, more than 50% of P. stomatis phagosomes recruited specific granules, as visualized by the granule marker lactoferrin. The lactoferrin-positive integrative pattern observed on P. stomatis phagosomes is an indication of granule fusion (31). Host proteins like lactoferrin can sequester iron, an important bacterial nutritional metal, and prevent microbial growth. It is possible that lactoferrin contributes to P. stomatis killing by inhibiting bacterial growth. Myeloperoxidase, present in the matrix of azurophil granules, is a key enzyme that uses hydrogen peroxide as a substrate to generate the toxic antimicrobial component hypochlorous acid (HOCl) (44). Our data showed that both specific and azurophil granules were efficiently recruited to P. stomatis phagosomes. Most likely, the fusion with and release of antimicrobial components, found in neutrophil granules, into the bacterial phagosome are the main contributors to P. stomatis decreased survival.
Chronic inflammation, as observed in periodontitis, is associated with increased levels of reactive oxygen radicals produced mainly by the high number of neutrophils in their attempt to control the dysbiotic bacterial challenge (2). The generation of ROS contributes to periodontal tissue damage and also to osteoclast activation (42). Circulating neutrophils from periodontitis patients display higher basal ROS production than those from healthy matched controls (32). Moreover, patient neutrophils challenged ex vivo with F. nucleatum or P. gingivalis display an enhanced extracellular ROS release, which indicates that those cells have a primed neutrophil phenotype (45). Cytokines and bacterial products can prime neutrophils for an enhanced respiratory burst response, which can augment the cell antimicrobial efficiency but can also contribute to tissue damage. Our study shows that P. stomatis challenge of human neutrophils did not result in the direct generation of superoxide release; however, the bacterium was able to prime the fMLF-stimulated respiratory burst. These observations indicate that P. stomatis has the ability to prime human neutrophils. Studies in the gut show that the production of ROS generated during inflammation, mainly by infiltrated neutrophils, provides a source of exogenous electron acceptors, which benefits the growth of some pathogenic microbial species (46). It is interesting to speculate that in the gingival pocket P. stomatis could contribute to maintaining high levels of ROS by priming neutrophils and help sustain a source of electron acceptors, which might benefit its growth and/or facilitate the growth of other members of the oral dysbiotic microbial community.
Neutrophils have four different types of granules, and their release is hierarchical and tightly regulated, with secretory vesicles being the most easily mobilizable and azurophil granules the last to be released. The actin cytoskeleton, microtubules, and the small GTPases are involved in different steps of granule trafficking, with different SNARE proteins involved in final membrane fusion events (28, 47). Degranulation of neutrophils with release of toxic antimicrobial cargo into the extracellular space contributes to the tissue damage observed during the course of periodontal disease. High levels of matrix metalloproteinases, such as MMP8 and MMP9, mainly derived from the neutrophil granule pool, are found in the crevicular fluid of periodontitis patients (48). Oral pathogens such as F. nucleatum, P. gingivalis, and T. denticola trigger the release of MMP9 from stimulated neutrophils, with P. gingivalis showing minimal levels of the 92-kDa band, due to its high proteolytic activity, compared to the other two oral pathogens (40). In our study, P. stomatis induced a time-dependent release of MMP9 from human neutrophils that was significantly higher than the response induced by fMLF. In addition, the gelatin zymography gels showed higher levels of the 92-kDa band, corresponding to MMP9, in the supernatants collected from P. stomatis-challenged human neutrophils than in the supernatants collected from P. gingivalis-challenged neutrophils.
Recruitment and fusion of azurophil granules to bacterium-containing phagosomes are key events in neutrophil phagosome maturation due to the highly antimicrobial content present in this granule subtype. Myeloperoxidase, neutrophil elastase, proteinase 3, and other serine proteases are important components of azurophil granules, all of which have microbicidal properties (18, 19, 44). Azurophil granule exocytosis is tightly controlled, and only 20% of the granule pool is mobilized, since release of proteases from the cell will damage host tissues (24, 50). As with MMPs, elevated levels of MPO are present in the gingival crevicular fluid of periodontitis patients, indicating that oral pathogens can trigger azurophil granule exocytosis (51, 52). In this study, we found that P. stomatis challenge of human neutrophils triggered both a time-dependent and a concentration-dependent release of MPO. Similarly, F. nucleatum, P. gingivalis, and T. denticola can induce the release of elastase from neutrophils, and Aggregatibacter actinomycetemcomitans can induce MPO release (40, 51, 52). In contrast, we recently showed that the newly recognized periodontal pathogen Filifactor alocis did not induce azurophil granule release even at a high multiplicity of infection (53). Hence, various neutrophil responses may contribute to the pathogenic potential of different pathogenic bacteria.
A pool of azurophil granules, characterized by the presence of the small GTPase Rab27a, localize close to the cell plasma membrane and undergo exocytosis instead of trafficking to the phagosome (54, 55). In our study, we observed by confocal staining of neutrophil elastase that azurophil granules were recruited to P. stomatis phagosomes and that the organism also induced exocytosis of this granule subtype. It is possible, therefore, that P. stomatis association with neutrophils triggers the mobilization of the Rab27a-positive subpopulation of azurophil granule.
In summary, we showed that P. stomatis is poorly phagocytosed by human neutrophils and that the internal bacteria are killed through oxygen-independent mechanisms, likely by recruitment of azurophil granules to the bacterium-containing phagosome. P. stomatis can prime neutrophils for an enhanced extracellular superoxide release upon subsequent stimulation. In addition, P. stomatis can induce robust mobilization of all four neutrophil granules with significant release of both MMP9 and MPO. The release of neutrophil granule content likely contributes to the significant extracellular killing of P. stomatis by neutrophils observed after 120 min. Overall, our data reveal that the emerging oral pathogen P. stomatis may limit its uptake by human neutrophils while promoting cell activation, which could contribute to damaging the host tissue.
MATERIALS AND METHODS
Human neutrophil isolation.
Neutrophils were isolated from healthy human donors and one individual with autosomal chronic granulomatous disease (CGD) using plasma-Percoll gradients (28) and in accordance with the guidelines approved by the Institutional Review Board of the University of Louisville. Microscopic evaluations of the isolated cells, using Wright staining (ENG Scientific, Inc.), showed that >90 to 95% of the cells were neutrophils. Trypan blue exclusion indicated that >97% of cells were viable.
Bacterial strains and growth conditions.
P. stomatis strain CM2 was cultured anaerobically at 37°C in tryptic soy broth supplemented with 20 g/liter yeast extract, 1% hemin, and 1% reducing agent (37.5 g/liter NH4Cl, 25 g/liter MgCl2·6H2O, 5 g/liter CaCl2·2H2O, 50 g/liter l-cysteine HCl, 5 g/liter FeCl2·4H2O). Nonviable bacteria were prepared by 90% isopropanol treatment under aerobic conditions for 10 min at room temperature. In order to remove residual isopropanol, the bacteria were washed twice in phosphate-buffered saline (PBS) buffer. Nonviability was confirmed by incubation in broth at 37°C for 24 h. For fluorescence assays, P. stomatis was labeled either with DAPI (10 μg/ml) or with CFSE (0.25 mg/ml) for 30 min at room temperature in the dark, and the cultures were washed 3 times with PBS prior to use. Porphyromonas gingivalis ATCC 33277 was cultured anaerobically at 37°C in Trypticase soy broth supplemented with yeast extract (1 mg/ml), hemin (5 μg/ml), and menadione (1 μg/ml).
Phagocytosis of P. stomatis by human neutrophils. (i) Imaging flow cytometry.
Isolated human neutrophils (4 × 106 cells/ml) were unstimulated or challenged either with human serum-opsonized or with nonopsonized CFSE-labeled P. stomatis at a multiplicity of infection (MOI) of 10 (unless otherwise noted). As a control, neutrophils were challenged with either human serum-opsonized or nonopsonized Alexa Fluor 488 heat-killed Staphylococcus aureus (Invitrogen) (MOI, 10). Cells were incubated in a shaking water bath at 37°C for 30 min or 120 min and then rinsed with 0.05% sodium azide and fixed with 1% paraformaldehyde. Images were obtained, quantified, and visualized using an Amnis ImageStreamX (Millipore). Labeled bacterial internalization was detected using excitation with a 488-nm solid-state laser (channel 2), and the bright-field microscopy images were detected in channel 1. A total of 1,000 neutrophil events were collected per condition and sorted into bacterium-positive or -negative bins based on CFSE/Alexa Fluor 488 intensity. The data were analyzed using the IDEAS Application v6.0 software (Amnis-Millipore). For each experiment, the internalization wizard was used to design a mask to count the CFSE- or Alexa Fluor 488-positive cells and to ignore positive signals from membrane-associated or extracellular bacteria.
(ii) Confocal microscopy.
Isolated human neutrophils (2 × 106 cells/ml) were stimulated with CFSE-labeled P. stomatis at an MOI of 10 and incubated in a shaking water bath at 37°C for 30 min. After incubation, the samples were rinsed once with RPMI medium, transferred to plates containing plasma-coated coverslips, and centrifuged at 600 × g for 8 min at 4°C. Cells were fixed with 10% formalin, and wheat germ agglutinin (WGA; Invitrogen) was used as a plasma membrane marker. Images were acquired by a Fluoview FV1000 confocal microscope and analyzed by FV-10ASW software (Olympus). To quantify the percentage of infection, 100 neutrophils were examined per condition, and the percentages of cells with bacteria internalized, attached to the plasma membrane, or both were calculated.
BacLight assay.
The combination of two DNA dyes, Sytox Green and DAPI, was used to determine bacteria viability associated with human neutrophils as previously described (21). Human neutrophils (2 × 106 cells/ml) were challenged with DAPI-labeled nonviable P. stomatis (as a control) or with DAPI-labeled viable P. stomatis or with both DPI (10 μM; Sigma)- and DAPI-labeled P. stomatis in a shaking water bath at 37°C for 30 min or 120 min. At each time point, the samples were transferred to plates containing plasma-coated coverslips and centrifuged at 600 × g for 8 min at 4°C. The membrane-impermeable dye Sytox Green (0.4 μM) in 0.1 MOPS (morpholinepropanesulfonic acid) (pH 7.2)–1 mM MgCl2 was added to detect bacterial cells with a compromised cell membrane. Confocal images were acquired within 30 min using a Fluoview FV1000 confocal microscope and analyzed by FV-10ASW software. Quantification was performed by counting the total viable and nonviable bacteria both intracellularly and extracellularly from 200 neutrophils in 3 independent experiments.
Intracellular respiratory burst response.
Isolated human neutrophils (4 × 106 cells/ml) were challenged with P. stomatis or with S. aureus at an MOI of 10 for 15 min or 30 min. The phagocytosis-stimulated respiratory burst response was measured by 2′, 7′-dichlorofluorescein (DCF; 5 μM) and analyzed by flow cytometry using a BD FACSCalibur as previously described (28). The nitroblue tetrazolium (NBT) assay was also used to visualize intracellular superoxide radical production induced by P. stomatis. Neutrophils (1 × 106 cells/ml) attached to plasma-coated glass coverslips were unstimulated or stimulated with S. aureus or with P. stomatis. Phagocytosis was synchronized at 600 × g and 14°C for 4 min, and cells were incubated at 37°C in 5% CO2 for 60 min in RPMI containing NBT. After incubation, cells were fixed with methanol and analyzed by light microscopy. Reduced NBT precipitates were visualized as blue formazan deposits.
Extracellular respiratory burst response.
Human neutrophils (4 × 106 cells/ml) were left unstimulated or were challenged with fMLF (300 nM; Sigma) for 5 min or with P. stomatis for 5, 15, or 30 min at 37°C. For neutrophil priming assays, neutrophils were pretreated with TNF-α (2 ng/ml) for 10 min or with P. stomatis for 10 min, followed by stimulation with fMLF (300 nM) for 5 min. After stimulation, the samples were centrifuged for 10 min at 600 × g and 4°C, and supernatants were collected. Superoxide anion release was measured spectrophotometrically at 550 nm as the superoxide dismutase-inhibitable reduction of ferricytochrome c as previously described (28).
Immunostaining of specific and azurophil granule recruitment.
The fusion of specific and azurophil granules with bacterium-containing phagosomes was tested by immunostaining using confocal microscopy as previously described (21, 31). Human neutrophils (2 × 106 cells/ml) were settled on human serum-coated coverslips, incubated in RPMI 1640 with 10% fetal bovine serum, and unstimulated or challenged with CFSE-labeled P. stomatis or S. aureus for 30 min. Following treatment, samples were fixed in 10% formalin, permeabilized in acetone-methanol at −20°C, and blocked in PBS containing 5% bovine serum albumin for 1 h at room temperature. Recruitment of specific granules to bacterium-containing phagosomes was determined with anti-human lactoferrin primary antibody (MP Biomedicals). Azurophil granule recruitment was determined with anti-neutrophil elastase antibody (AHN-10; Millipore). The secondary antibody utilized was Alexa Fluor 555 (Life Technologies), and DAPI was used as a nuclear stain. Confocal images and z-stacks (1-μm thickness for each slice) were obtained using a Fluoview FV1000 confocal microscope with a 63× oil objective to determine specific and azurophil granule recruitment to bacterium-containing phagosomes. To quantify the enrichment of the bacterium-containing phagosomes for a granule subtype, 100 neutrophils were counted per condition, and if ≥50% of the phagosome was surrounded by lactoferrin or elastase, it was considered positive granule marker recruitment, as previously described (21).
Neutrophil granule exocytosis.
Isolated human neutrophils (4 × 106 cells/ml) were suspended in buffer (basal) or stimulated with fMLF (300 nM) for 5 min or challenged with P. stomatis or P. gingivalis at an MOI of 10, 50, or 100 for 30 min; or they were pretreated with TNF-α (2 ng/ml; R&D Systems) for 10 min, followed by fMLF (300 nM) for 5 min. Exocytosis of azurophil granules, specific granules, and secretory vesicles was determined by measuring the increase in plasma membrane expression of membrane-associated receptors using antibodies: fluorescein isothiocyanate (FITC)-conjugated CD63 (clone AHN16.1/46-4-5; Ancell Corporation), FITC-conjugated anti human CD66b (clone G10F5; Biolegend), and phycoerythrin (PE)-conjugated anti-human CD35 (clone E11; Biolegend), respectively. After appropriate treatment, the samples were washed with 0.5% sodium azide, fixed with 1% paraformaldehyde, and analyzed by flow cytometry using a BD FACSCalibur instrument as previously described (28). Extracellular releases of MMP-9 (a marker for gelatinase granule exocytosis) and myeloperoxidase (MPO; a marker for azurophil granule exocytosis) were measured in the neutrophil supernatants collected from the experimental conditions described above by MMP-9 (Boster) and MPO (Abcam) enzyme-linked immunosorbent assays (ELISAs) in accordance with the manufacturer's instructions. The activities of MMP-9 in the supernatants from the same experimental conditions were analyzed by gelatin zymogen assays. Briefly, gelatin zymography was performed by using a 9% SDS-PAGE gel saturated with 1 mg/ml gelatin (300 bloom; Sigma Chemical). Samples (10 μg) with equal protein concentration were loaded onto the gel and electrophoresed at a constant 100 V for 2.5 h. The gels were incubated for 1 h at room temperature in 2.5% Triton X-100, followed by an overnight incubation at 37°C in gelatinase substrate buffer (50 mM Tris, 10 mM CaCl2, and 0.02% NaN2 [pH 8.0]). The gels were stained with 0.5% Coomassie blue followed by subsequent destaining with 50% methanol. Densitometry of the 92-kDa band intensity was quantified using ImageJ software.
Statistical analysis.
Statistical analysis was performed using Student's t test or one-way analysis of variance (ANOVA) with the posttest Tukey-Kramer multiple comparison using GraphPad Prism software. Differences were considered significant at P levels of <0.05.
ACKNOWLEDGMENTS
We thank Terri Manning for neutrophil isolation and Alison K. Criss for her advice and expertise with bacteria viability, BacLight, and neutrophil granule immunostaining assays.
We declare that no conflicting interests exist.
We thank the NIH/NIDCR for funding through DE017921 and DE011111 (R.J.L.) and Consejo Nacional de Ciencia y Tecnologia (CONACYT) (E.J.F).
REFERENCES
- 1.Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. 2015. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol 86:611–622. doi: 10.1902/jop.2015.140520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 8:481–490. doi: 10.1038/nrmicro2337. [DOI] [PubMed] [Google Scholar]
- 3.Sosroseno W, Herminajeng E. 1995. The immunopathology of chronic inflammatory periodontal disease. FEMS Immunol Med Microbiol 10:171–180. doi: 10.1111/j.1574-695X.1995.tb00030.x. [DOI] [PubMed] [Google Scholar]
- 4.Davé S, Van Dyke TE. 2008. The link between periodontal disease and cardiovascular disease is probably inflammation. Oral Dis 14:95–101. doi: 10.1111/j.1601-0825.2007.01438.x. [DOI] [PubMed] [Google Scholar]
- 5.Kaur S, White S, Bartold PM. 2013. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res 92:399–408. doi: 10.1177/0022034513483142. [DOI] [PubMed] [Google Scholar]
- 6.Shub A, Swain JR, Newnham JP. 2006. Periodontal disease and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 19:521–528. doi: 10.1080/14767050600797749. [DOI] [PubMed] [Google Scholar]
- 7.Hajishengallis G, Lamont RJ. 2012. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol 27:409–419. doi: 10.1111/j.2041-1014.2012.00663.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hajishengallis G, Lamont RJ. 2016. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol 24:477–489. doi: 10.1016/j.tim.2016.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kistler JO, Pesaro M, Wade WG. 2015. Development and pyrosequencing analysis of an in-vitro oral biofilm model. BMC Microbiol 15:1–10. doi: 10.1186/s12866-014-0320-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. 2005. Identification of candidate periodontal pathogens and beneficial species by quantitative 16s clonal analysis. J Clin Microbiol 43:3944–3955. doi: 10.1128/JCM.43.8.3944-3955.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Murphy EC, Frick I-M. 2013. Gram-positive anaerobic cocci—commensals and opportunistic pathogens. FEMS Microbiol Rev 37:520–553. doi: 10.1111/1574-6976.12005. [DOI] [PubMed] [Google Scholar]
- 12.Sizova MV, Chilaka A, Earl AM, Doerfert SN, Muller PA, Torralba M, McCorrison JM, Durkin AS, Nelson KE, Epstein SS. 2015. High-quality draft genome sequences of five anaerobic oral bacteria and description of Peptoanaerobacter stomatis gen. nov., sp. nov., a new member of the family Peptostreptococcaceae. Stand Genomic Sci 10:37. doi: 10.1186/s40793-015-0027-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Oren A, Garrity GM. 2016. List of new names and new combinations previously effectively, but not validly, published. Int J Syst Evol Microbiol 66:4299–4305. doi: 10.1099/ijsem.0.001585. [DOI] [PubMed] [Google Scholar]
- 14.Downes J, Wade WG. 2006. Peptostreptococcus stomatis sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol 56:751–754. doi: 10.1099/ijs.0.64041-0. [DOI] [PubMed] [Google Scholar]
- 15.Ryder MI. 2010. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 53:124–137. doi: 10.1111/j.1600-0757.2009.00327.x. [DOI] [PubMed] [Google Scholar]
- 16.Scott DA, Krauss J. 2012. Neutrophils in periodontal inflammation. Front Oral Biol 15:56–83. doi: 10.1159/000329672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. doi: 10.1038/nri3399. [DOI] [PubMed] [Google Scholar]
- 18.Quinn MT, DeLeo FR, Bokoch GM. 2007. Neutrophil methods and protocols. Preface. Methods Mol Biol 412:vii–viii. [DOI] [PubMed] [Google Scholar]
- 19.Nordenfelt P, Tapper H. 2011. Phagosome dynamics during phagocytosis by neutrophils. J Leukoc Biol 90:271–284. doi: 10.1189/jlb.0810457. [DOI] [PubMed] [Google Scholar]
- 20.Reference deleted.
- 21.Johnson MB, Criss AK. 2013. Neisseria gonorrhoeae phagosomes delay fusion with primary granules to enhance bacterial survival inside human neutrophils. Cell Microbiol 15:1323–1340. doi: 10.1111/cmi.12117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Herrero-Turrión MJ, Calafat J, Janssen H, Fukuda M, Mollinedo F. 2008. Rab27a regulates exocytosis of tertiary and specific granules in human neutrophils. J Immunol 181:3793–3803. doi: 10.4049/jimmunol.181.6.3793. [DOI] [PubMed] [Google Scholar]
- 23.Uriarte SM, Powell DW, Luerman GC, Merchant ML, Cummins TD, Jog NR, Ward RA, McLeish KR. 2008. Comparison of proteins expressed on secretory vesicle membranes and plasma membranes of human neutrophils. J Immunol 180:5575–5581. doi: 10.4049/jimmunol.180.8.5575. [DOI] [PubMed] [Google Scholar]
- 24.Borregaard N, Sørensen OE, Theilgaard-Mönch K. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 28:340–345. doi: 10.1016/j.it.2007.06.002. [DOI] [PubMed] [Google Scholar]
- 25.Sengelov H, Kjeldsen L, Borregaard N. 1993. Control of exocytosis in early neutrophil activation. J Immunol 150:1535–1543. [PubMed] [Google Scholar]
- 26.Reference deleted.
- 27.Matthews JB, Wright HJ, Roberts A, Ling-Mountford N, Cooper PR, Chapple ILC. 2007. Neutrophil hyper-responsiveness in periodontitis. J Dent Res 86:718–722. doi: 10.1177/154405910708600806. [DOI] [PubMed] [Google Scholar]
- 28.Uriarte SM, Rane MJ, Luerman GC, Barati MT, Ward RA, Nauseef WM, McLeish KR. 2011. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. J Immunol 187:391–400. doi: 10.4049/jimmunol.1003112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Allen L-AH, Beecher BR, Lynch JT, Rohner OV, Wittine LM. 2005. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 174:3658–3667. doi: 10.4049/jimmunol.174.6.3658. [DOI] [PubMed] [Google Scholar]
- 30.Lee J-W, O'Brien CN, Guidry AJ, Paape MJ, Shafer-Weaver KA, Zhao X. 2005. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis. Can J Vet Res 69:11–18. [PMC free article] [PubMed] [Google Scholar]
- 31.Monfregola J, Johnson JL, Meijler MM, Napolitano G, Catz SD. 2012. Munc13-4 protein regulates the oxidative response and is essential for phagosomal maturation and bacterial killing in neutrophils. J Biol Chem 287:44603–44618. doi: 10.1074/jbc.M112.414029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Uriarte SM, Edmisson JS, Jimenez-Flores E. 2016. Human neutrophils and oral microbiota: a constant tug-of-war between a harmonious and a discordant coexistence. Immunol Rev 273:282–298. doi: 10.1111/imr.12451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Condliffe AM, Kitchen E, Chilvers ER. 1998. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 94:461–471. doi: 10.1042/cs0940461. [DOI] [PubMed] [Google Scholar]
- 34.Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, Dang PM, El-Benna J. 2014. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol 1124:405–412. doi: 10.1007/978-1-62703-845-4_23. [DOI] [PubMed] [Google Scholar]
- 35.Mair YH, Jhamb T, Visser MB, Aguirre A, Kramer JM. 2016. Sera and salivary matrix metalloproteinases are elevated in patients with vesiculoerosive disease: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 121:520–529. doi: 10.1016/j.oooo.2016.01.002. [DOI] [PubMed] [Google Scholar]
- 36.Olsen I, Hajishengallis G. 2016. Major neutrophil functions subverted by Porphyromonas gingivalis. J Oral Microbiol 8:30936. doi: 10.3402/jom.v8.30936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Miyasaki KT. 1991. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 62:761–774. doi: 10.1902/jop.1991.62.12.761. [DOI] [PubMed] [Google Scholar]
- 38.Yamazaki T, Miyamoto M, Yamada S, Okuda K, Ishihara K. 2006. Surface protease of Treponema denticola hydrolyzes C3 and influences function of polymorphonuclear leukocytes. Microbes Infect 8:1758–1763. doi: 10.1016/j.micinf.2006.02.013. [DOI] [PubMed] [Google Scholar]
- 39.Katsuragi H, Ohtake M, Kurasawa I, Saito K. 2003. Intracellular production and extracellular release of oxygen radicals by PMNs and oxidative stress on PMNs during phagocytosis of periodontopathic bacteria. Odontology 91:13–18. doi: 10.1007/s10266-003-0022-1. [DOI] [PubMed] [Google Scholar]
- 40.Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T. 1997. Release and activation of human neutrophil matrix metallo and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol 24:237–248. doi: 10.1111/j.1600-051X.1997.tb01837.x. [DOI] [PubMed] [Google Scholar]
- 41.Remer KA, Reimer T, Brcic M, Jungi TW. 2005. Evidence of involvement of peptidoglycan in the triggering of an oxidative burst by Listeria monocytogenes in phagocytes. Clin Exp Immunol 140:73–80. doi: 10.1111/j.1365-2249.2005.02740.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Chapple ILC, Matthews JB. 2007. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 43:160–232. doi: 10.1111/j.1600-0757.2006.00178.x. [DOI] [PubMed] [Google Scholar]
- 43.Sztukowska M, Bugno M, Potempa J, Travis J, Kurtz DM Jr. 2002. Role of rubrerythrin in the oxidative stress response of Porphyromonas gingivalis. Mol Microbiol 44:479–488. doi: 10.1046/j.1365-2958.2002.02892.x. [DOI] [PubMed] [Google Scholar]
- 44.Nauseef WM. 2014. Myeloperoxidase in human neutrophil host defence. Cell Microbiol 16:1146–1155. doi: 10.1111/cmi.12312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Matthews JB, Wright HJ, Robersts A, Cooper PR, Chapple IL. 2007. Hyper-activity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin Exp Immunol 147:255–264. doi: 10.1111/j.1365-2249.2006.03276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rivera-Chávez F, Bäumler AJ. 2015. The pyromaniac inside you: Salmonella metabolism in the host gut. Annu Rev Microbiol 69:31–48. doi: 10.1146/annurev-micro-091014-104108. [DOI] [PubMed] [Google Scholar]
- 47.Ramadass M, Catz SD. 2016. Molecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammation. Immunol Rev 273:249–265. doi: 10.1111/imr.12452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N. 2001. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 72:1398–1406. doi: 10.1902/jop.2001.72.10.1398. [DOI] [PubMed] [Google Scholar]
- 49.Reference deleted.
- 50.Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. 1995. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 154:4157–4165. [PubMed] [Google Scholar]
- 51.Sheikhi M, Gustafsson A, Jarstrand C. 2000. Cytokine, elastase and oxygen radical release by Fusobacterium nucleatum-activated leukocytes: a possible pathogenic factor in periodontitis. J Clin Periodontol 2000 27:758–762. [DOI] [PubMed] [Google Scholar]
- 52.Miyasaki KT, Nemirovskiy E. 1997. Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria. Oral Microbiol Immunol 12:27–32. doi: 10.1111/j.1399-302X.1997.tb00363.x. [DOI] [PubMed] [Google Scholar]
- 53.Armstrong CL, Miralda I, Neff AC, Tian S, Vashishta A, Perez L, Le J, Lamont RJ, Uriarte SM. 2016. Filifactor alocis promotes neutrophil degranulation and chemotactic activity. Infect Immun 84:3423–3433. doi: 10.1128/IAI.00496-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Munafo DB, Johnson JL, Ellis BA, Rutschmann S, Beutler B, Catz SD. 2007. Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes. Biochem J 402:229–239. doi: 10.1042/BJ20060950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Johnson JL, Brzezinska AA, Tolmachova T, Munafo DB, Ellis BA, Seabra MC, Hong H, Catz SD. 2010. Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms. Traffic 11:533–547. doi: 10.1111/j.1600-0854.2009.01029.x. [DOI] [PMC free article] [PubMed] [Google Scholar]